Jaffe, Allan S.
Cardiac Biomarkers
Part I. Ischemic Heart Disease
1. Pre-analytical Factors and Analytical Issues Affecting Interpretation of Cardiovascular Biomarkers
Amy K. Saenger
2. Troponin Basics for Clinicians
Yader Sandoval, Fred S. Apple
3. Unique Aspects of High Sensitivity Assays: What Are They, Why Do We Need Them, and How Do We Use Them?
Paul Ormandy Collinson
4. Evaluation of Patients Presenting with Chest Pain in the Emergency Department: Where Do Troponins Fit In?
Martin Paul Than, Louise Cullen
5. Using Cardiac Troponins in Patients with Acute Myocardial Infarction
Johannes Mair, Kristian Thygesen
6. What Is a Type 2 Myocardial Infarction: How Is It Recognized and What Should One Do to Establish That Diagnosis?
Joseph S. Alpert, Allan S. Jaffe
7. Use of Cardiac Troponin in Patients with Heart Failure
Wayne L. Miller
8. Elevated cTn in Other Acute Situations Such as Atrial Fibrillation, Sepsis, Respiratory Failure, and Gastrointestinal Bleeding
Evangelos Giannitsis, Hugo A. Katus
9. Use of cTn for Detection of More Chronic Disease States
Ravi H. Parikh, Christopher R. deFilippi
10. Use of High-Sensitive cTn Assays for the Evaluation of Patients Potentially at Risk for Cardiovascular Disease
Kai M. Eggers, Per Venge
11. Other Biomarkers in Acute Coronary Syndrome
Roxana Ghashghaei, Nicholas Marston
12. Newer Lipid Markers: Apolipoprotein B, LDL Particle Concentration, and Triglyceride-Rich Lipoproteins – When Are They Needed?
Renato Quispe, Seth S. Martin, Steven R. Jones
Part II. Heart Failure
13. Natriuretic Peptides: Physiology for the Clinician
Siu-Hin Wan, Horng H. Chen
14. Natriuretic Peptides: Basic Analytic Considerations
Alan H. B. Wu
15. Natriuretic Peptide Use in Screening in the Community
Noel S. Lee, Lori B. Daniels
16. Natriuretic Peptide Use in the Emergency Department
W. Frank Peacock, Salvator DiSomma
17. Heart Failure: Natriuretic Peptide Use in the Hospital
Kevin Shah, James Iwaz
18. Natriuretic Peptide Guided Therapy in Outpatient Heart Failure Management
Matthew N. Peters, Christopher R. deFilippi
19. Caveats Using Natriuretic Peptide Levels
Trenton M. Gluck, Kevin Shah, Alan S. Maisel
20. Gaps in Our Biomarker Armamentarium: What Novel Biomarkers Might Be Synergistic in Patients with Acute Disease
Bertil Lindahl
21. Biomarkers in Heart Failure: ST2
Antoni Bayes-Genis, Josep Lupón
22. Biomarkers in Heart Failure: Procalcitonin
Martin Möckel, Julia Searle
23. Novel Biomarkers in Heart Failure: Adrenomedullin and Proenkephalin
Daniel Chan, Leong Ng
24. Biomarkers in Specific Disease States: Cardio-Oncology
Ugochukwu O. Egolum, Daniel J. Lenihan
25. Biomarkers of Sarcopenia and Mitochondrial Dysfunction
Boris Arbit, Elizabeth Lee, Pam R. Taub
26. Biomarkers in Arrhythmias, Sudden Death, and Device Therapy
David E. Krummen, Lori B. Daniels
27. Biomarkers in Cardio-Renal Dysfunction
Nicholas Phreaner, Alex Pearce, Alan S. Maisel
28. Biomarkers in Heart Failure with Preserved Ejection Fraction
Robert Colbert, Rohit Mital, Nicholas Marston
Keywords: Medicine & Public Health, Cardiology
- Editor
- Jaffe, Allan S.
- Maisel, Alan S.
- Publisher
- Springer
- Publication year
- 2016
- Language
- en
- Edition
- 1
- Page amount
- 18 pages
- Category
- Medicine, Health Care, Mode
- Format
- Ebook
- eISBN (PDF)
- 9783319429823
- Printed ISBN
- 978-3-319-42980-9